Severity of Nail Psoriasis Score (SNAPS) demonstrates longitudinal construct validity against the modified nail psoriasis severity index (mNAPSI) in an observed cohort of patients with Psoriatic arthritis

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Abstract

Background: Longitudinal observational data on psoriatic nail dystrophy is scarce, in part due to the lack of a validated outcome measure that is feasible in routine care. The Severity of Nail Psoriasis Score (SNAPS; range 0-40: scored one point each for the presence of pitting, onycholysis, hyperkeratosis and/or severe nail disease# in each fingernail) has face validity and has recently demonstrated feasibility, reliability and cross-sectional construct validity against the modified Nail Psoriasis Severity Index (mNAPSI; range 0-130)1. Objectives: We aimed to assess the longitudinal construct validity of SNAPS against the mNAPSI and physician nail VAS (PhNVAS), and to determine the effect size and measurement error of these tools. Methods: Consenting consecutive patients enrolled in the Bath Psoriatic Arthritis (PsA) longitudinal cohort underwent photography of their fingernails at baseline1 and 6 months alongside routine clinical assessments. Dorsal images of individual fingernails were acquired using a tripod mounted DSLR camera. An angled mirror positioned distally aided identification of hyperkeratosis. Photograps were scored using SNAPS, mNAPSI and PhNVAS1. Paired statistical analyses were conducted to assess for change in scores from baseline to follow-up. Pairwise correlations between change in SNAPS and change in mNAPSI and PhyNVAS were assessed using Spearman’s rho. Effect sizes and measurement error were calculated. Results: Fifteen patients with a mean (±SD) age of 54.5 (±10.59) were assessed at 6 months. There was a significant reduction in both the mNAPSI and SNAPS scores (p<0.005), with improvements in the most frequently-observed manifestations1 i.e. pitting, onycholysis, hyperkeratosis and crumbling (Table 1). No other feature specific to mNAPSI improved over time. There was no significant change using the PhyNVAS. There was a strong correlation between changes in SNAPS and the mNAPSI (Figure 1; rho = 0.838, p<0.001). The correlation between change in SNAPS and PhyNVAS was not statistically significant (rho =0.45, p=0.095) (Figure 1). The change in mNAPSI correlated moderately with the PhNVAS (rho = 0.540, p=0.038). mNAPSI was superior to SNAPS in most parameters of measurement error (Table 2). The mNAPSI and SNAPS had similar effect sizes as measured by the SRM (Table 2). Conclusion: SNAPS demonstrates longitudinal construct validity against the mNAPSI in a small observational cohort of PsA patients as evidenced by a strong correlation between the measures, comparable effect sizes and sensitivity to change over time. Whilst measurement error parameters favored the mNAPSI, SNAPS may be a more feasible measure for studying nail disease in cohort studies. References: [1]Antony A, Hart D, Cavill C, Korendowych E, McHugh N, Lovell C, Tillett W. The ‘Severity of Nail Psoriasis Score’ (SNAPS) Is Feasible, Reliable and Demonstrates Construct Validity Against the mNAPSI in an Observational Cohort of Patients with Psoriatic Arthritis
Original languageEnglish
Article numberAB0735
Pages (from-to)1662
Number of pages1
JournalAnnals of the Rheumatic Diseases
Volume79
Issue numberS1
Publication statusPublished - Jun 2020
EventAnnual European Congress of Rheumatology (EULAR) 2020 - online
Duration: 3 Jun 20206 Jun 2020
https://blogs.biomedcentral.com/bmcseriesblog/2020/06/17/eular-2020-highlights-from-the-european-e-congress-of-rheumatology/

Cite this